Cyclin-dependent kinase 5 is associated with risk for Alzheimer's diseasein a Dutch population-based study

A (Alejandro) Arias Vasquez, YS Aulchenko, Aaron Isaacs, Andy Oosterhout, K (Kristel) Sleegers, Bert Hofman, C van Broeckhoven, Ben Oostra, Monique Breteler, Cornelia Duijn

Research output: Contribution to journalArticleAcademicpeer-review

16 Citations (Scopus)

Abstract

Although the role of the Cdk5 protein in Alzheimer's disease (AD) is well recognized, there have been relatively few studies investigating genetic variants in the CDK5 gene in AD. In this study, we assessed the association between five previously described single nucleotide polymorphisms (SNPs) in the CDK5 gene and late onset AD by means of logistic regression and haplotype association analyses. Including all prevalent and incident AD cases, we found a significantly increased risk of AD for carriers of the GG genotype of SNP rs2069442 (OR=1.79, 95% CI 1.16-2.79, p = 0.001) in those without APOE*4. When limiting the analysis to incident cases without APOE*4, carriers of the GG genotype showed a 1.9-fold increased risk of AD (95% CI 1.16-3.10, p = 0.003). Variations in the CDK5 gene can be described in 5 haplotype blocks. In our analysis, the haplotype tagged by the G allele of SNP rs2069442 was significantly associated with AD (p = 0.05). In conclusion, our study suggests that CDK5 may be associated with AD.
Original languageUndefined/Unknown
Pages (from-to)655-662
Number of pages8
JournalJournal of Neurology
Volume255
Issue number5
DOIs
Publication statusPublished - 2008

Research programs

  • EMC MGC-02-96-01
  • EMC NIHES-01-64-02

Cite this